Zhuhai Hengqin Walvax

  • Hengqin fund registered, to focus on biomedicine investments

    Zhuhai Hengqin Walvax, a private equity (PE) fund has officially registered at Asset Management Association of China (AMAC). This is the third private equity asset allocation funds of Jinsheng Capital and the sixth in China. Jinsheng became one of the first three and the only five private equity allocation fund managers in the country.